These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 6202963

  • 21. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH, Hainer JW, Sugg J, M-FACT Study Group.
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G, Cottone S, Mangano MT, D'Ignoto G, Pinto A, Carone MB.
    Clin Ther; 1988 Apr; 10(6):694-703. PubMed ID: 2975530
    [Abstract] [Full Text] [Related]

  • 24. Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers.
    Sluiter HE, Huysmans FT, Thien TA, van Lier HJ, Koene RA.
    Drugs; 1985 Apr; 29 Suppl 2():26-35. PubMed ID: 2985351
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients.
    Edgar B, Collste P, Haglund K, Regårdh CG.
    Clin Invest Med; 1987 Sep; 10(5):388-94. PubMed ID: 3677507
    [Abstract] [Full Text] [Related]

  • 26. Comparative trial of felodipine and nifedipine in refractory hypertension.
    Aberg H, Lindsjö M, Mörlin B.
    Drugs; 1985 Sep; 29 Suppl 2():117-23. PubMed ID: 3886357
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W, Wilson T.
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [Abstract] [Full Text] [Related]

  • 29. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B, Hosie J.
    Blood Press Suppl; 1993 Jun; 1():22-9. PubMed ID: 8173687
    [Abstract] [Full Text] [Related]

  • 30. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM, Malmberg L, Teräväinen TL, Laakso J, Vapaatalo H, Karppanen H.
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [Abstract] [Full Text] [Related]

  • 31. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A, Grilli M, Forte P, Morales E, Velasco M.
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [Abstract] [Full Text] [Related]

  • 32. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
    Dahlöf B, Jönsson L, Borgholst O, Ekblad G, Engstrand C, Grundestam I, Lindh A.
    Blood Press Suppl; 1993 Sep; 1():37-45. PubMed ID: 8173689
    [Abstract] [Full Text] [Related]

  • 33. Baroreflex control of heart rate and renin release in SHR following administration of felodipine, an antihypertensive Ca2+ antagonist.
    Nordlander M, Horton R, Thalén P.
    J Cardiovasc Pharmacol; 1987 Sep; 10 Suppl 10():S120-1. PubMed ID: 2455110
    [Abstract] [Full Text] [Related]

  • 34. Renal effects of felodipine in hypertensive patients with reduced renal function.
    Herlitz H, Aurell M, Björck S, Granérus G.
    Drugs; 1985 Sep; 29 Suppl 2():192-7. PubMed ID: 3987548
    [Abstract] [Full Text] [Related]

  • 35. Acute antihypertensive and hormonal effects of a calcium antagonist in essential hypertension.
    Thibonnier M, Corvol P, Banzet O, Menard J.
    J Cardiovasc Pharmacol; 1982 Sep; 4 Suppl 3():S335-9. PubMed ID: 6184564
    [Abstract] [Full Text] [Related]

  • 36. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function].
    Wambach G, Godehardt E, Lang R, Haerlin R, Meurer KA.
    Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693
    [Abstract] [Full Text] [Related]

  • 37. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J, Mora-Macià J, Castellet R, del Río G.
    Med Clin (Barc); 1994 Jan 22; 102(2):41-5. PubMed ID: 8133694
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring.
    Podjarny E, Korzets Z, Bernheim J.
    J Hum Hypertens; 1996 Sep 22; 10 Suppl 3():S153-6. PubMed ID: 8872849
    [Abstract] [Full Text] [Related]

  • 39. Felodipine. A calcium-inhibiting vasodilator in refractory hypertension.
    Andersson OK, Granérus G, Hedner T.
    Drugs; 1985 Sep 22; 29 Suppl 2():102-8. PubMed ID: 3886356
    [Abstract] [Full Text] [Related]

  • 40. [Multicenter comparative study of felodipine-ER and nifedipine-OROS in the treatment of mild-to-moderate arterial hypertension].
    Batlouni M, Leite Luna R, Castro I, Silveira Sbissa A, Armaganijan D, Chaves Junior Hde C, Nobre F, Pereira da Cunha C.
    Arq Bras Cardiol; 1996 Apr 22; 66(4):247-51. PubMed ID: 8935693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.